Liquid-based cervical cytology is no more sensitive or specific than a conventional Pap smear for detecting high-grade cervical intraepithelial neoplasia, according to a recent systematic review and meta-analysis conducted in the Netherlands.
Liquid-based cervical cytology is no more sensitive or specific than a conventional Pap smear for detecting high-grade cervical intraepithelial neoplasia, according to a recent systematic review and meta-analysis conducted in the Netherlands.
Upon reviewing eight relevant studies and one randomized clinical trial published between 1991 and 2007 that all employed gold standard verification of results, the authors of the meta-analysis concluded that other than a slightly lower specificity for liquid-based cytology when atypical squamous cells of undetermined significance is the cutoff (OR, 0.91; 95% CI, 0.84-0.98), virtually no difference exists between the two methods.
Other factors that could tip the scale one way or the other when choosing which method to use include whether samples for liquid-based cytology are compromised when they are first used for conventional Pap smear, that cytotechnologists and pathologists consistently prefer liquid-based cytology because the uniform spread of epithelial cells in a thin layer facilitates microscopic interpretation, and that the liquid-based technology is more costly.
Arbyn M, Bergeron C, Klinkhamer P, et al. Liquid compared with conventional cervical cytology: a systematic review and meta-analysis. Obstet Gynecol. 2008;111:167-177.
SART data indicates rise in IVF use in 2022
April 24th 2024Dive into the latest statistics from the Society for Assisted Reproductive Technology, revealing a 6% increase in in vitro fertilization cycles and a surge in egg freezing, amidst a landscape of rising fertility service demand and evolving clinical practices.
Read More
Hormone therapy safety: Study finds potential benefits for senior women
April 24th 2024A recent large-scale study challenged age-related concerns, suggesting hormone therapy may offer safety and even benefits for menopausal women aged over 65 years, aligning with The Menopause Society's 2022 Position Statement.
Read More